FAM217A and cancer: Although other 10 identified DEGs expressions were not correlated with prognosis, including CREBBP, ANXA5, EPB41L4A-AS1, FAM217A, IFI27L2, LNX2, MED28, TACR1, TLE4, and ZNF763, they may act as cancer stem cells (CSCs) markers, especially CREBBP and IFI27L2 (Figure 2C).